Tag: Diabetes: Type II
More Diabetes Remission in T2DM Seen With Low-Carb Diets for Six Months
Large clinically important improvements observed in weight loss, triglycerides, and insulin sensitivity, which decreased at 12 months
Albuminuria Down in Adults With Newly Diagnosed T2DM
Improvements seen in glycemic, blood pressure, lipid control within the population partly explain decrease in albuminuria
Euglycemic DKA ID’d in T2DM Patients With COVID-19
Five cases of euDKA identified in patients with type 2 diabetes using SGLT2 inhibitors who developed SARS-CoV-2 infection
Intensive Glycemic Control May Cut CV Autonomic Neuropathy Risk
Greatest CAN prevention effect seen among type 2 diabetes patients without cardiovascular disease history
Age at T2DM Diagnosis Inversely Linked to Risk for Adverse Outcomes
One-year increase in age at diabetes diagnosis linked to lower risk for all-cause mortality and macrovascular, microvascular disease
Risk of Severe COVID-19 Up Among Those With Diabetes
Risk for severe COVID-19 similar among those with type 1 and type 2 diabetes
Risk for Fatal Cardiovascular Events High in Many T2DM Patients
More than one-third of T2DM patients without established cardiovascular disease had very high risk for CV events
CVD Risk Higher in T2DM Even With Optimal Risk Factor Management
Those with T2DM with optimal risk factor control have greater risk for cardiovascular disease events versus those without T2DM
AHA: Sotagliflozin Beneficial for T2DM With Heart Failure
Second study shows benefits among patients with type 2 diabetes and chronic kidney disease, risks for CVD
Mediterranean Diet Cuts Type 2 Diabetes Risk in Women
Risk reduction driven by improvement in insulin resistance, lipoprotein metabolism, and inflammation
